695 related articles for article (PubMed ID: 22907569)
1. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
Arbyn M; Verdoodt F; Snijders PJ; Verhoef VM; Suonio E; Dillner L; Minozzi S; Bellisario C; Banzi R; Zhao FH; Hillemanns P; Anttila A
Lancet Oncol; 2014 Feb; 15(2):172-83. PubMed ID: 24433684
[TBL] [Abstract][Full Text] [Related]
3. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
4. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
5. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
Gök M; van Kemenade FJ; Heideman DA; Berkhof J; Rozendaal L; Spruyt JW; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
Int J Cancer; 2012 Mar; 130(5):1128-35. PubMed ID: 21484793
[TBL] [Abstract][Full Text] [Related]
6. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
Bokan T; Ivanus U; Jerman T; Takac I; Arko D
Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
[TBL] [Abstract][Full Text] [Related]
7. Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.
Porras C; Hildesheim A; González P; Schiffman M; Rodríguez AC; Wacholder S; Jiménez S; Quint W; Guillen D; Kreimer AR; Herrero R;
J Natl Cancer Inst; 2015 Jan; 107(1):400. PubMed ID: 25479804
[TBL] [Abstract][Full Text] [Related]
8. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
[TBL] [Abstract][Full Text] [Related]
9. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
13. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
[TBL] [Abstract][Full Text] [Related]
14. Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
Boggan JC; Walmer DK; Henderson G; Chakhtoura N; McCarthy SH; Beauvais HJ; Smith JS
Sex Transm Dis; 2015 Nov; 42(11):655-9. PubMed ID: 26462192
[TBL] [Abstract][Full Text] [Related]
15. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
Tranberg M; Jensen JS; Bech BH; Andersen B
BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
[TBL] [Abstract][Full Text] [Related]
17. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
18. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
Ogilvie GS; Krajden M; van Niekerk DJ; Martin RE; Ehlen TG; Ceballos K; Smith LW; Kan L; Cook DA; Peacock S; Stuart GC; Franco EL; Coldman AJ
Br J Cancer; 2012 Dec; 107(12):1917-24. PubMed ID: 23169286
[TBL] [Abstract][Full Text] [Related]
19. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders.
Gök M; Heideman DA; van Kemenade FJ; de Vries AL; Berkhof J; Rozendaal L; Beliën JA; Overbeek L; Babović M; Snijders PJ; Meijer CJ
Eur J Cancer; 2012 Aug; 48(12):1799-808. PubMed ID: 22172570
[TBL] [Abstract][Full Text] [Related]
20. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
